...BRCA2. We performed a matched case-control study of 1,260 pairs of women with known BRCA1 or BRCA2 mutations, recruited ...
...BRCA2 (19.4%). By looking at the protein level, the changes observed within the BRCA1 and BRCA2 genes could affect not o...
...BRCA2. EMSY contains an approximately 100-residue segment at the amino terminus called the ENT (EMSY N-terminal) domain....
...BRCA2 mutations have an increased risk of contralateral breast cancer and cancer of the ovary. Furthermore, recent resea...
...BRCA2 (P-BRCA2) proteins in breast cell lines after different treatments was carried out. Cells were cultivated with [35...
...BRCA2. In sporadic breast cancer, however, there is evidence for the involvement of a different pathway of DNA repair, n...
...BRCA2 mutation identified are commonly suggested to consider ovarian carcinoma screening with transvaginal ultrasound an...
Germline mutations in either BRCA1 or BRCA2 genes are responsible for the majority of hereditary breast and ovarian canc...
...BRCA2 account for approximately half the cases of autosomal dominant familial breast cancers. BRCA2 has been shown to in...
...BRCA2 mutation carriers and patients with a prior history of breast cancer, is discussed. SOURCES AND STUDY SELECTION: W...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2026.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
